Immediate Impact
55 standout
Citing Papers
Gel/hydrogel‐based in situ biomaterial platforms for cancer postoperative treatment and recovery
2023 Standout
Pharmacology and Clinical Development of Factor XI Inhibitors
2023 Standout
Works of E. Mazoyer being referenced
PT, aPTT, TT and the hemostatic safety threshold of dabigatran and rivaroxaban
2016
Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| E. Mazoyer | 145 | 187 | 136 | 216 | 161 | 31 | 707 | |
| Miriam Barbanti | 62 | 74 | 70 | 157 | 163 | 23 | 664 | |
| Crosby Wh | 224 | 128 | 169 | 158 | 77 | 28 | 727 | |
| Egidio Marchi | 99 | 129 | 75 | 128 | 179 | 39 | 785 | |
| B.M. Errichi | 28 | 86 | 389 | 407 | 91 | 42 | 835 | |
| Christoph Pechlaner | 73 | 139 | 55 | 61 | 66 | 35 | 628 | |
| Francesca Fortini | 42 | 148 | 46 | 84 | 236 | 36 | 843 | |
| G. Acerbi | 15 | 80 | 274 | 347 | 137 | 31 | 793 | |
| Anders Wallmark | 191 | 45 | 54 | 137 | 188 | 29 | 792 | |
| Saravanan Subramaniam | 227 | 63 | 83 | 53 | 225 | 29 | 753 | |
| Danuta Owczarek | 90 | 31 | 38 | 157 | 176 | 50 | 841 |
All Works
Loading papers...